Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) Short Interest Update

Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) was the recipient of a significant decline in short interest in the month of June. As of June 30th, there was short interest totaling 3,880 shares, a decline of 68.0% from the June 15th total of 12,119 shares. Based on an average trading volume of 24,174 shares, the short-interest ratio is presently 0.2 days. Currently, 1.0% of the shares of the company are sold short.

Defiance Daily Target 2X Long LMND ETF Stock Performance

Defiance Daily Target 2X Long LMND ETF stock traded down $0.01 during trading hours on Friday, hitting $18.59. The stock had a trading volume of 8,274 shares, compared to its average volume of 43,894. The company has a 50-day moving average of $14.13 and a two-hundred day moving average of $21.46. The company has a quick ratio of 6.08, a current ratio of 8.37 and a debt-to-equity ratio of 0.52. Defiance Daily Target 2X Long LMND ETF has a fifty-two week low of $10.17 and a fifty-two week high of $55.00. The company has a market cap of $6.88 million, a PE ratio of 36.45 and a beta of 9.35.

Defiance Daily Target 2X Long LMND ETF Company Profile

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays.